IMMUNOVANT, INC. — Cash Flow Charts
1 years of history · ending 2024-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-214M
Free Cash Flow
$-215M
Investing Cash Flow
$-360K
Financing Cash Flow
$472M
Capex
$360K
Stock-Based Comp
$41M
D&A
$231K
SBC Allocated Expense
$41M